Tecvayli

Pharma

FDA 'proactively' awards J&J a national priority review voucher

The FDA granted the CNPV to J&J's combination of Tecvayli and Darzalex in multiple myeloma just a few days after a detailed phase 3 data presentation.

Angus Liu Dec 15, 2025 12:33pm

ASH: J&J pressures CAR-T with Tecvayli combo in 2L myeloma

Dec 9, 2025 7:30am

J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win

Oct 16, 2025 8:10am

J&J reports $133M in sales for new multiple myeloma med Tecvayli

Apr 16, 2024 11:28am

CAR-T hype faces infrastructure reality check

Jan 15, 2024 3:00am

JPM24: J&J CEO thinks key launches can outdo analyst estimates

Jan 8, 2024 3:11pm